BVS
Bioventus Inc.
Key Financials
Revenue
$568.1M
↓ 0.9%
Operating Income
$54.0M
↑ 550.6%
Net Income
$22.7M
↑ 167.8%
Total Assets
$683.6M
↓ 6.1%
Cash & Equivalents
$51.2M
↑ 23.2%
Total Liabilities
$455.1M
↓ 16.1%
Gross Profit
$388.2M
↓ 0.0%
EPS (Diluted)
$0.33
↑ 163.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 6/4/2026 | View on SEC |
| 4 | 6/4/2026 | View on SEC |
| 4 | 6/4/2026 | View on SEC |
| 4 | 6/4/2026 | View on SEC |
| 4 | 6/4/2026 | View on SEC |
| 4 | 6/4/2026 | View on SEC |
| 4 | 6/4/2026 | View on SEC |
| 4 | 6/4/2026 | View on SEC |
| 4 | 6/4/2026 | View on SEC |
| 4 | 6/4/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BVS |
| Company Name | Bioventus Inc. |
| CIK | 1665988 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (919) 474-6700 |